{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
<< Return to MedStarHealth.org
MedStar Health
  • Sign In
  • Conferences
  • RSS
  • Online Courses
  • Learning from Teaching
  • Podcasts
  • Contact Us
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
MedStar associates, you will log in to CloudCME with your SiTEL Learning Management System (SITELMS) account on the next screen.

If you are not a MedStar associate, you can log in or create an account on the next screen.

For login assistance, contact the SiTEL Help Center at 1-855-745-1861 (Mon-Fri 8 AM to 5 PM) or at [email protected]
I am a MedStar Associate (login via SiTEL)
I am Not a MedStar Associate
Enter your email and password to login:



Login

New to CloudCME? Create an Account:

Create New Account
Back to Login Provider Forgot Your Password?

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##






Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =


  • -- Select Degree --
  • AAS
  • BSN
  • BSND
  • BSRT
  • CCT
  • CNM
  • CRNP
  • CRNP, RN
  • CVT
  • DNP
  • DO
  • DPM
  • DPM, MS
  • DPM. MPH
  • DPT
  • JD
  • LCSW-C
  • LMSW
  • LPN
  • MA
  • MBBS, DTMH
  • MD
  • MD, FACC
  • MD, FACS
  • MD, JD
  • MD, MBA
  • MD, MPH
  • MD, MSc, MBA
  • MD, PhD
  • MD, PhD, MS
  • MGC, CGC
  • MHA
  • MPH
  • MPT
  • MS
  • MS, MPH, CGC
  • MSN
  • MSOTR/L, CLT
  • MSPH
  • MSW
  • None
  • NP
  • Other
  • OTR
  • PA
  • PharmD
  • PhD
  • PsyD
  • PT
  • PT, DPT
  • RCES
  • RCIS
  • RD
  • RDN
  • RN
  • RN, BSN
  • RN, BSN, CCRN, CWON
  • RT

Please enter your degree:





Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

D.C. Lung Cancer Conference 2023


D.C. Lung Cancer Conference 2023 Banner

  • Overview
  • Register
  • Faculty
  • Schedule
  • Brochure
  • Venue
  • Exhibitors
Add to Calendar D.C. Lung Cancer Conference 2023 10/7/2023 7:30:00 AM 10/7/2023 5:30:00 PM America/New_York For More Details: https://medstar.cloud-cme.com/course/courseoverview?P=0&EID=26337 Description: This one-day conference will provide a comprehensive, multidisciplinary update on recent clinical advances in lung cancer. The field is evolving very rapidly and over the past year, there have been major shifts in our understanding of this highly lethal disease. We have seen high impact advances in all aspects of lung cancer management: from detection to diagnosis to treatment. The D.C. Lung Canc... The Mayflower Hotel false MM/DD/YYYY


Date & Location
Saturday, October 7, 2023, 7:30 AM - 5:30 PM, The Mayflower Hotel, Washington, DC

Target Audience
Specialties - Internal Medicine, Medical Oncology, Oncology, Pathology, Pulmonology, Radiation Oncology, Radiology, Surgery
Professions - Non-Physician, Nurse, Pharmacist, Physician, Student

Overview

This one-day conference will provide a comprehensive, multidisciplinary update on recent clinical advances in lung cancer. The field is evolving very rapidly and over the past year, there have been major shifts in our understanding of this highly lethal disease. We have seen high impact advances in all aspects of lung cancer management: from detection to diagnosis to treatment. The D.C. Lung Cancer Conference will emphasize current best practices for busy clinicians who care for patients with lung cancer, across disciplines. High impact, engaging didactic lectures will be delivered by international thought leaders and well-respected faculty in each field. An opening talk from a patient advocate will provide important perspective. There will be updates on CT screening, proper use of liquid biopsy, interpretation of molecular testing results and review of smoking cessation techniques. A section will be dedicated to optimizing multidisciplinary care for early stage and locally advanced lung cancer to include discussions on modern bronchoscopy, proton beam radiation, minimally invasive surgery and both neoadjuvant and adjuvant systemic therapy. Sessions with important updates on targeted therapy and immunotherapy will feature recognized experts in the field and there will be a debate over use of emerging biomarkers to guide treatment of advanced NSCLC. Attendees will have the opportunity to interact with faculty in frequent Q&A sessions with access to presentation materials for later review.

 

This Conference is endorsed by:

 



Objectives
After completing this activity, the participant will be able to:

  1. Identify the benefit of CT screening for lung cancer.
  2. List the currently approved targeted options for patients with MET exon 14 mutant lung cancer.
  3. Explain the approved use of targeted therapy for KRAS-mutant non-small cell lung cancer.
  4. Describe the role of the patient advocate in clinical research.
  5. Discuss the current application of liquid biopsy (or ctDNA analysis).
  6. Debate the use of targeted therapy for patients with resected EGFR mutant non-small cell lung cancer.
  7. Explain the toxicity associated with targeted therapy given after immunotherapy in EGFR mutant non-small cell lung cancer.
  8. Explain the approved adjuvant and neoadjuvant treatment options for resectable, driver negative non-small cell lung cancer.
  9. Explain the significance and use of patient centered communications on the patient and family experience.
  10. Summarize strategies for navigating conversations with patients and families.
  11. Discuss standard targeted agents in use for patients with ALK-positive non-small cell lung cancer.
  12. Discuss management of immune-mediated toxicities.
  13. Describe the benefit of immunotherapy in the treatment of small cell lung cancer.
  14. Describe the approved use of tumor treating fields.
  15. Identify nursing strategies for early detection of immune-mediated toxicities.
  16. Recognize unique toxicities associated with targeted agents used in NSCLC.
  17. Describe current standard care for advanced mesothelioma.
  18. Discuss standard initial therapy for advanced small cell lung cancer (SCLC).
  19. Identify the roles and responsibilities of members of the healthcare team involved in the collaborative care of patients with lung cancer.
  20. Integrate a team-based approach in the care of patients with lung cancer.

Registration

Advance Purchase and Onsite Rate August 7 to October 7

  • Physician $200
  • IASLC Member $140
  • Resident/Fellow $0
  • Physician Assistant $125
  • Nurse Practitioner $125
  • Nurse $125
  • Pharmacist $125
  • Allied Health Professional $125
  • Patient Advocate $100
  • Industry Professional  $275

Please contact [email protected] or (833) 731-1273 for registration assistance


Accreditation

 In support of improving patient care, MedStar Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Credit Designation Statement

This activity was planned by and for the healthcare team and learners will receive 6.75 Interprofessional Continuing Education (IPCE) credits for learning and change.

 

 

Physicians: MedStar Health designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

American Board of Internal Medicine MOC Credit

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

MOC Participation Threshold

Learner participates by writing a reflective statement and makes a commitment to change or maintain an element of practice.

Nurses: This activity is approved for 6.75 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacists: This activity is approved for 6.75 contact hours. This learning activity is knowledge-based. The Universal Activity Number for this program is UAN# JA4008151-0000-23-030-L05-P.


Credits
AMA PRA Category 1 Creditsâ„¢ Physician (6.75 hours), Nurse - ANCC (6.75 hours), Non-Physician Member of the Healthcare Team (6.75 hours), Pharmacist - ACPE (6.75 hours), IPCE (6.75 hours), ABIM MOC Part 2 (6.75 hours)

The Mayflower Hotel

1127 Connecticut Ave NW

Washington, DC 20036

Hotel arrangements can be made online at: book.passkey.com/go/MedstarHealth2023

Hotel Cutoff Date: September 8, 2023




Mitigation of Relevant Financial Relationships


MedStar Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education.

 
Individuals in a position to control the content of this CE activity, including faculty, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible companies. An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All of the relevant financial relationships listed below have been mitigated prior to the commencement of the activity.



Faculty Member Information
Role in activity
Name of Ineligible Company(s) / Nature of Relationship(s)
Faculty Photos
Stephen V. Liu, MD
Director, Thoracic Medical Oncology, Director, Phase I Developmental Therapeutics, Associate Professor, Medicine
MedStar Georgetown University Hospital, Georgetown University Medical Center
Washington, DC
Activity Co-Director, Faculty
Advisor-Amgen|Advisor-AstraZeneca AstraZeneca|Advisor-AbbVie|Advisor-BMS|Advisor-Catalyst (Relationship has ended)|Advisor-Daiichi Sankyo, Inc.|Advisor-Eisai|Advisor-Elevation Oncology|Advisor-Genentech, Inc.|Advisor-Gilead Sciences, Inc.|Advisor-Guardant Health|Advisor-Janssen|Advisor-Jazz Pharmaceuticals|Advisor-Merus|Consulting Fee-Merck|Advisor-Novartis Pharmaceuticals|Advisor-Regeneron|Advisor-Sanofi|Advisor-Takeda|Advisor-Turning Point Therapeutics|Grant or research support-Alkermes|Grant or research support-Elevation Oncology|Grant or research support-Genentech, Inc.|Grant or research support-Gilead Sciences, Inc.|Grant or research support-Merck|Grant or research support-Merus|Grant or research support-Nuvalent|Grant or research support-RAPT|Grant or research support-Turning Point Therapeutics
Faculty Photos
Nagla F. Abdel Karim, MD
Medical Oncologist, Professor, Medicine
Inova Health System, University of Virginia
Fairfax, VA
Faculty
Speakers Bureau-Regeneron|Speakers Bureau-Astra Zeneca Astra Zeneca|Grant or research support-Astra Zeneca Astra Zeneca|Grant or research support-Exelixis|Grant or research support-Genentech, Inc.
Faculty Photos
Eric D. Anderson, MD
Director, Interventional Pulmonology; Professor, Clinical Medicine; Pulmonary, Critical Care and Sleep Medicine
MedStar Georgetown University Hospital, Georgetown University Medical Center
Washington, DC
Faculty
Honoraria-Intuitive Surgical
Faculty Photos
Amin Benyounes, MD
Thoracic Medical Oncologis
Inova Health System, University of Maryland School of Medicine
Fairfax, VA
Faculty
Nothing to disclose
Faculty Photos
Hossein Borghaei, DO, MS
Chief, Division of Thoracic Medical Oncology, Professor, Department of Hematology/Oncology
The Gloria and Edmund M. Dunn Chair in Thoracic Oncology Fox Chase Cancer Center
Philadelphia, PA
Faculty
Grant or research support-BMS|Grant or research support-Lilly Oncology|Grant or research support-Amgen|Consulting Fee-BMS|Consulting Fee-Lilly Oncology|Consulting Fee-Genentech, Inc.|Consulting Fee-Pfizer, Inc.|Consulting Fee-Merck|Consulting Fee-EMD Serono|Consulting Fee-Boehringer Ingelheim|Consulting Fee-Novartis Pharmaceuticals|Consulting Fee-Genmab|Consulting Fee-Regeneron|Consulting Fee-Amgen|Consulting Fee-Takeda|Consulting Fee-Daiichi Sankyo, Inc.|Consulting Fee-Janssen|Consulting Fee-Natera (Relationship has ended)|Consulting Fee-Pharmamar|Consulting Fee-Beigene|Consulting Fee-Guardant|Consulting Fee-Oncocyte (Relationship has ended)|Consulting Fee-Jazz|Consulting Fee-Da Volterra (Relationship has ended)|Consulting Fee-iTEO (Relationship has ended)|Consulting Fee-Mirati|Consulting Fee-Puma|Consulting Fee-BerGenBio|Other: DSMB-Incyte|Other: DSMB-Springwork|Other: DSMB-Takeda (Relationship has ended)|Other: DSMB-Novartis Pharmaceuticals|Other: DSMB-U of Penn|Stocks or stock options, excluding diversified mutual funds-Sonnetbio|Stocks or stock options, excluding diversified mutual funds-Inspirna|Stocks or stock options, excluding diversified mutual funds-Nucleai|Honoraria-Regeneron (Relationship has ended)|Honoraria-Pfizer, Inc. (Relationship has ended)|Honoraria-Amgen (Relationship has ended)|Honoraria-Daiichi Sankyo, Inc. (Relationship has ended)
Faculty Photos
Ibiayi Dagogo-Jack, MD
Thoracic Oncologist, Assistant Professor, Medicine
Massachusetts General Hospital, Harvard Medical School
Boston, MA
Faculty
Grant or research support-Novartis Pharmaceuticals|Grant or research support-Pfizer, Inc.
Faculty Photos
Giuseppe Esposito, MD
Chief, Division of Nuclear Medicine, Professor, Radiology
MedStar Georgetown University Hospital, Georgetown University School of Medicine
Washington, D.C.
Faculty
Speakers Bureau-Advanced Accelerator Applications (Relationship has ended)
Faculty Photos
Jill Feldman, MA
Lung Cancer Patient and Advocate, Co-Founder
EGFR Lung Cancer Resisters
Deerfield, IL
Faculty
Consulting Fee-Janssen|Consulting Fee-Blueprint Medicines
Faculty Photos
Narjust Florez, MD
Thoracic Medical oncologist, Associate Director, Cancer Care Equity Program, Member of the Faculty, Medicine
Dana-Farber Brigham Cancer Center, Harvard Medical School
Boston, MA
Faculty
Advisor-Regeneron|Advisor-Astra Zeneca Astra Zeneca|Advisor-Daiichi Sankyo, Inc.|Advisor-Novartis Pharmaceuticals|Advisor-Merck|Advisor-Pfizer, Inc.|Advisor-Janssen|Speakers Bureau-Neogenomics
Faculty Photos
Patrick Forde, NA
Director, Thoracic Oncology Clinical Research Program, Co-Director, Division of Upper Aerodigestive Malignancies, Associate Professor, Oncology
Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial, Johns Hopkins University School of Medicine
Baltimore, MD
Faculty
Advisor-AbbVie|Advisor-Astra Zeneca Astra Zeneca|Advisor-Bristol-Myers Squibb|Advisor-Merck|Advisor-Novartis Pharmaceuticals|Advisor-Genentech, Inc.|Grant or research support-Astra Zeneca Astra Zeneca|Grant or research support-Bristol-Myers Squibb|Grant or research support-Regeneron
Faculty Photos
Marina Chiara Garassino, MBBS
Director, Thoracic Oncology Program, Professor, Medicine
The University of Chicago Medicine
Chicago, IL
Faculty
Honoraria-Merck (Merck Sharp & Donhme a subsidiary of Merck & Co, Inc.) (Relationship has ended)|Honoraria-Astra Zeneca Astra Zeneca (Relationship has ended)|Honoraria-GlaxoSmithKline (Relationship has ended)|Honoraria-Takeda (Relationship has ended)|Honoraria-Roche (Relationship has ended)|Honoraria-Bristol-Myers Squibb (Relationship has ended)|Honoraria-Daiichi Sankyo, Inc. (Relationship has ended)|Honoraria-Regeneron (Relationship has ended)|Honoraria-Pfizer, Inc. (Relationship has ended)|Honoraria-Blueprint Medicines (Relationship has ended)|Honoraria-Novartis Pharmaceuticals (Relationship has ended)|Honoraria-Sanofi (Relationship has ended)|Advisor-Bristol-Myers Squibb (Relationship has ended)|Advisor-Merck (Merck Sharp & Donhme a subsidiary of Merck & Co, Inc.) (Relationship has ended)|Advisor-Astra Zeneca Astra Zeneca (Relationship has ended)|Advisor-Novartis Pharmaceuticals (Relationship has ended)|Advisor-Takeda (Relationship has ended)|Advisor-Roche (Relationship has ended)|Advisor-Sanofi (Relationship has ended)|Advisor-Celgene (Relationship has ended)|Advisor-Daiichi Sankyo, Inc. (Relationship has ended)|Advisor-Pfizer, Inc. (Relationship has ended)|Advisor-Eli Lilly andCompany (Relationship has ended)|Advisor-GlaxoSmithKline (Relationship has ended)|Advisor-Bayer Corporation (Relationship has ended)|Advisor-Blueprint Medicines (Relationship has ended)|Advisor-Janssen (Relationship has ended)|Advisor-Regeneron (Relationship has ended)|Advisor-Bayer Corporation (Relationship has ended)|Advisor-AbbVie (Relationship has ended)|Advisor-Merck (Relationship has ended)|Advisor-Incyte (Relationship has ended)|Advisor-Takeda (Relationship has ended)|Advisor-Blueprint Medicines (Relationship has ended)|Advisor-Eli Lilly andCompany (Relationship has ended)|Advisor-Astra Zeneca Astra Zeneca (Relationship has ended)|Advisor-Exelixis (Relationship has ended)|Advisor-Sanofi (Relationship has ended)|Advisor-Amgen (Relationship has ended)
Faculty Photos
Ryan D. Gentzler, MD
Medical Oncologist, Thoracic Oncology, Associate Professor, Medicine
University of Virginia Comprehensive Cancer Center
Charlottesville, VA
Faculty
Grant or research support-Pfizer, Inc.|Grant or research support-Amgen|Grant or research support-Chugai|Grant or research support-Merck|Grant or research support-Astra Zeneca Astra Zeneca|Grant or research support-Janssen|Grant or research support-Daiichi Sankyo, Inc.|Grant or research support-Takeda
Faculty Photos
Balazs Halmos, MD
Director, Thoracic/Head and Neck Oncology, Professor, Medicine
Montefiore Medical Center, Albert Einstein College of Medicine
Bronx, NY
Faculty
Consulting Fee-Boehringer Ingelheim|Consulting Fee-BMS|Consulting Fee-Merck|Grant or research support-AbbVie|Consulting Fee-Amgen|Grant or research support-Daiichi Sankyo, Inc.|Grant or research support-GlaxoSmithKline|Consulting Fee-Janssen|Consulting Fee-Novartis Pharmaceuticals|Consulting Fee-Genentech, Inc.|Consulting Fee-Pfizer, Inc.|Consulting Fee-Takeda|Consulting Fee-Veracyte
Faculty Photos
Faysal Haroun, MD
Fellowship Program Director, Assistant Professor, Medicine, Division of Hematology & Oncology
The George Washington University School of Medicine and Health Sciences
Washington, D.C.
Faculty
Honoraria-Amgen
Faculty Photos
Raffit Hassan, MD
Chief, Thoracic and GI Malignancies Branch, CCR, NCI
National Institutes of Health
Bethesda, MD
Faculty
Grant or research support-Bayer Corporation
Faculty Photos
Chul Kim, MD, MPH
Thoracic Medical Oncologist, Assistant Professor, Medicine
MedStar Georgetown University Hospital, Georgetown University Medical Center
Washington, D.C.
Faculty
Consulting Fee-Novartis Pharmaceuticals|Consulting Fee-Regeneron|Consulting Fee-Astra Zeneca Astra Zeneca|Consulting Fee-Janssen|Consulting Fee-Eisai|Consulting Fee-Daiichi Sankyo, Inc.|Consulting Fee-Jazz|Consulting Fee-Arcus|Consulting Fee-Mirati|Consulting Fee-Sanofi|Consulting Fee-Janssen|Consulting Fee-Diffuse pharmaceuticals|Grant or research support-Bristol-Myers Squibb|Grant or research support-Novartis Pharmaceuticals|Grant or research support-Regeneron|Grant or research support-Karyopharm|Grant or research support-Debiopharm|Grant or research support-Janssen|Grant or research support-Genentech, Inc.|Grant or research support-Spectrum|Grant or research support-Merck (Relationship has ended)|Grant or research support-Lyell|Grant or research support-Daiichi Sankyo, Inc.|Grant or research support-Blueprint Medicines
Faculty Photos
Ticiana Leal, MD
Director, Thoracic Medical Oncology, Associate Professor, Medicine Department of Hematology & Oncology
Winship Cancer Institute, Emory University
Decatur, GA
Faculty
Advisor-Daiichi Sankyo, Inc. (Relationship has ended)|Advisor-Eisai (Relationship has ended)|Advisor-Novocure (Relationship has ended)|Advisor-Amgen (Relationship has ended)|Advisor-Roche (Relationship has ended)|Consulting Fee-Genentech, Inc. (Relationship has ended)|Advisor-AstraZeneca AstraZeneca (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Regeneron|Advisor-Takeda (Relationship has ended)|Advisor-Merck (Relationship has ended)|Advisor-Jazz (Relationship has ended)|Consulting Fee-Catalyst Orthoscience|Membership on Advisory Committees or Review Panels, Board Membership, etc.-OncoC4|Advisor-Pfizer, Inc. (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Janssen|Advisor-Sanofi (Relationship has ended)
Faculty Photos
Natasha B. Leighl, MD, MMSc
Lung Site Lead, Medical Oncology, Professor, Medicine, Adjunct Professor, Medicine
Princess Margaret Cancer Centre, University of Toronto, Dalla Lana School of Public Health
Toronto, Canada
Faculty
Grant or research support-Inivata
Faculty Photos
Benjamin P. Levy, MD
Thoracic Medical Oncologist, Clinical Director, Medical Oncology; Associate Professor, Oncology
Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital, Johns Hopkins University School of Medicine
Washington, D.C.
Faculty
Advisor-Janssen|Advisor-Pfizer, Inc.|Advisor-Janssen|Advisor-Amgen|Advisor-Genentech, Inc.|Advisor-Eli Lilly andCompany|Advisor-Takeda|Advisor-Gilead|Advisor-Daiichi Sankyo, Inc.|Advisor-Novartis Pharmaecuticals|Advisor-Sanofi
Faculty Photos
Jessica J. Lin, MD
Medical Oncologist, Attending Physician Center for Thoracic Cancers; Attending Physician, Henri and Belinda Termeer Center for Targeted Therapies; Assistant Professor, Medicine
Massachusetts General Hospital, Harvard Medical School
Boston, MA
Faculty
Paid consultant-Nuvalent|Paid consultant-Turning Point Therapeutics|Paid consultant-Bayer Corporation|Paid consultant-Mirati Therapeutics|Paid consultant-Blueprint Medicines (Relationship has ended)|Paid consultant-Elevation Oncology|Paid consultant-Genentech, Inc.|Paid consultant-Novartis Pharmaceuticals (Relationship has ended)|Paid consultant-Pfizer, Inc.|Grant or research support-Hengrui Therapeutics|Grant or research support-Turning Point Therapeutics|Grant or research support-Neon Therapeutics|Grant or research support-Relay Therapeutics|Grant or research support-Bayer Corporation|Grant or research support-Elevation Oncology|Grant or research support-Roche|Grant or research support-Linnaeus Therapeutics|Grant or research support-Nuvalent|Grant or research support-Novartis Pharmaceuticals|Paid consultant-Regeneron (Relationship has ended)|Paid consultant-Takeda|Paid consultant-Ellipses Pharma|Paid consultant-Haiku Biosciences|Paid consultant-Claim Therapeutics|Paid consultant-AnHeart Therapeutics
Faculty Photos
Laura Macke, MS, FNP-C, AOCNP
Nurse Practitioner
MedStar Georgetown University Hospitall
Washington, D.C.
Faculty
Consulting Fee-RenovoRx
Faculty Photos
Michael E. Menefee, MD
Assistant Professor, Medicine
George Washington University School of Medicine, Washington, DC VA Medical Center
Washington, D.C.
Faculty
Nothing to disclose
Faculty Photos
Drew Moghanaki, MD, MPH
Professor of Radiation Oncology
UCLA Health
Santa Monica, CA
Faculty
Consulting Fee-Astra Zeneca Astra Zeneca|Advisor-Merck (Relationship has ended)
Faculty Photos
Nitika Paudel, MD, PhD
Radiation Oncologist, Radiation Medicine; Assistant Professor, Radiation Medicine
MedStar Georgetown University Hospital, Georgetown University School of Medicine
Washington, D.C.
Faculty
Speakers Bureau-Astra Zeneca Astra Zeneca (Relationship has ended)
Faculty Photos
Zofia Piotrowska, MD, MHS
Medical Oncologist, Assistant Professor, Medicine
Massachusetts General Hospital, Harvard Medical School
Boston, MA
Faculty
Advisor-Astra Zeneca Astra Zeneca (Relationship has ended)|Consulting Fee-Blueprint Medicines (Relationship has ended)|Advisor-Daiichi Sankyo, Inc. (Relationship has ended)|Advisor-Bayer Corporation (Relationship has ended)|Advisor-Merck (Relationship has ended)|Advisor-Sanofi Genzyme (Relationship has ended)|Advisor-Janssen (Relationship has ended)|Advisor-Taiho Oncology (Relationship has ended)|Consulting Fee-Eli Lilly andCompany (Relationship has ended)|Consulting Fee-Janssen (Relationship has ended)|Consulting Fee-Daiichi Sankyo, Inc. (Relationship has ended)|Advisor-Takeda (Relationship has ended)|Advisor-Cullinan Oncology (Relationship has ended)|Grant or research support-Novartis Pharmaceuticals|Grant or research support-Takeda|Grant or research support-Spectrum (Relationship has ended)|Grant or research support-AstraZeneca AstraZeneca|Grant or research support-Tesaro, Inc.|Grant or research support-Cullinan Oncology|Grant or research support-Daiichi Sankyo, Inc.|Grant or research support-AbbVie|Grant or research support-Janssen|Grant or research support-Blueprint Medicines
Faculty Photos
Joshua E. Reuss, MD
Thoracic Medical Oncologist; Assistant Professor, Medicine
MedStar Georgetown University Hospital, Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center
Washington, DC
Faculty
Grant or research support-Genentech, Inc.|Honoraria-Merck|Paid consultant-Seagen|Grant or research support-Nuvalent|Paid consultant-Daiichi Sankyo, Inc.|Paid consultant-Bristol-Myers Squibb|Paid consultant-Arcus|Paid consultant-Oxford Biodynamics|Paid consultant-AbbVie|Paid consultant-Gilead|Paid consultant-Personalis|Paid consultant-AstraZeneca AstraZeneca|Paid consultant-Guardant|Paid consultant-Sanofi|Grant or research support-verastem
Faculty Photos
Katherine A. Scilla, MD, FACP
Medical Oncologist, Assistant Professor, Medicine
University of Maryland, University of Maryland School of Medicine
Baltimore, MD
Faculty
Membership on Advisory Committees or Review Panels, Board Membership, etc.-Mirati Therapeutics (Relationship has ended)
Faculty Photos
Susan C. Scott, MD, MA
Thoracic Medical Oncologist, Assistant Professor, Oncology
Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital, Johns Hopkins University School of Medicine
Washington, D.C.
Faculty
Consulting Fee-Genentech, Inc.|Consulting Fee-Tempus|Grant or research support-Janssen|Grant or research support-Mirati Therapeutics|Consulting Fee-Astra Zeneca Astra Zeneca|Consulting Fee-Foundation Medicine|Consulting Fee-Regeneron
Faculty Photos
Elaine Shum, MD
Medical Oncologist, Assistant Professor, Medicine
NYU Langone’s Perlmutter Cancer Center, NYU Grossman School of Medicine
New York, NY
Faculty
Advisor-AstraZeneca AstraZeneca|Advisor-Boehringer Ingelheim|Advisor-Blueprint Medicines|Grant or research support-Delfi Diagnostics
Faculty Photos
Jonathan Spicer, MD
Associate Professor of Surgery
McGill University
Montreal, Quebec, Canada
Faculty
Advisor-Merck|Advisor-BMS|Advisor-Astra Zeneca Astra Zeneca|Advisor-Roche|Grant or research support-AstraZeneca AstraZeneca|Grant or research support-Roche (Relationship has ended)|Grant or research support-BMS|Grant or research support-Merck
Faculty Photos
Alexander I. Spira, MD
Director, Thoracic and Phase I Program, Co-Director, VCS Research Institute, Clinical Assistant Professor, Oncology
Virginia Cancer Specialists
Fairfax, VA
Faculty
Stocks or stock options, excluding diversified mutual funds-Eli Lilly andCompany|Honoraria-AstraZeneca AstraZeneca|Honoraria-Merck|Honoraria-Takeda|Honoraria-Amgen|Honoraria-Janssen|Honoraria-Novartis Pharmaceuticals|Honoraria-Bristol-Myers Squibb|Honoraria-Bayer Corporation|Advisor-Incyte|Advisor-Amgen|Advisor-Novartis Pharmaceuticals|Advisor-Takeda|Advisor-Janssen|Advisor-Daiichi Sankyo, Inc.|Advisor-Regeneron|Advisor-Lilly Oncology|Advisor-Sanofi|Advisor-Array BioPharma|Advisor-Astra Zeneca Astra Zeneca|Advisor-Merck|Advisor-Bristol-Myers Squibb|Advisor-Blueprint Medicines|Grant or research support-Regeneron|Grant or research support-Roche|Grant or research support-Astra Zeneca Astra Zeneca|Grant or research support-Boehringer Ingelheim|Grant or research support-Astellas|Grant or research support-Novartis Pharmaceuticals|Grant or research support-Incyte|Grant or research support-AbbVie|Grant or research support-Takeda|Grant or research support-Macrogenics|Grant or research support-Bristol-Myers Squibb|Grant or research support-Amgen|Grant or research support-Daiichi Sankyo, Inc.|Grant or research support-Janssen|Grant or research support-Rubius|Grant or research support-Synthekine|Grant or research support-Blueprint Medicines|Honoraria-CyomX Therapeutics|Advisor-Mirati Therapeutics|Advisor-Gritstone Oncology|Advisor-Jazz Pharmaceuticals|Advisor-Mersana|Advisor-Black Diamond Therapeutics|Grant or research support-LAM Therapeutics|Grant or research support-MedImmune|Grant or research support-Ignyta|Grant or research support- CytomX Therapeutics|Grant or research support-Astex Pharmaceuticals|Grant or research support-Loxo|Grant or research support-Arch Therapeutics|Grant or research support-Gritstone|Grant or research support-Plexxikon|Grant or research support-ADCT|Grant or research support-Mirati Therapeutics|Grant or research support-mersana|Grant or research support-Alkermes|Grant or research support-Revolution Medicines|Grant or research support-Medikine|Grant or research support-nalo therapeutics|Grant or research support-Scorpion Therapeutics|Grant or research support-ArriVent Biopharma
Faculty Photos
Brendon M. Stiles, MD
Associate Director, Surgical Services, Professor and Chief, Thoracic Surgery and Surgical Oncology
Montefiore-Einstein Cancer Center, Albert Einstein College of Medicine, Montefiore Medical Center
New York, NY
Faculty
Advisor-AstraZeneca AstraZeneca|Advisor-Genentech, Inc.|Advisor-Galvanize Therapeutics|Advisor-Merck (Merck Sharp & Donhme a subsidiary of Merck & Co, Inc.)|Advisor-Regeneron|Advisor-Bristol-Myers Squibb|Advisor-Pfizer, Inc.|Advisor-Medtronic, Inc.|Grant or research support-BMS
Faculty Photos
Irina G. Veytsman, MD
Section Director, Hematology/Oncology Medical Oncologist
MedStar Georgetown Cancer Institute, MedStar Washington Hospital Center
Washington, D.C.
Faculty
Nothing to disclose
Faculty Photos
Randi M. Williams, PhD, MPH
Assistant Professor, Oncology
Georgetown University
Washington, D.C.
Faculty
Nothing to disclose
Faculty Photos
Ann E. Hwalek, MD
Attending Physician, Thoracic Surgery, Assistant Professor, Medicine
MedStar Georgetown University Hospital, Georgetown University School of Medicine
Washington , DC
Faculty, Planner Content Reviewer
Nothing to disclose
Faculty Photos
Jennifer A. Marks, MD
Hematologist & Medical Oncologist
MedStar Georgetown University Hospital
Washington, DC
Faculty, Planner Content Reviewer
Nothing to disclose
Faculty Photos
Marybeth V. Kazanas, PharmD
Senior Director, Clinical Pharmacy Services
MedStar Health
Columbia, MD
Planning Committee Member
Nothing to disclose
Faculty Photos
Jillian E. Thompson, ANP-BC, AOCNP
Nurse Practitioner
MedStar Georgetown University Hospital
Washington, D.C.
Planning Committee Member
Membership on Advisory Committees or Review Panels, Board Membership, etc.-Novartis Pharmaceuticals (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Janssen (Relationship has ended)|Speakers Bureau-Regeneron

Saturday, October 7, 2023

Registration, Continental Breakfast, and Visit the Exhibits
7:30AM - 8:00AM
Welcome and Introduction
8:00AM - 8:05AM
Stephen V. Liu, MD
Session I: Diagnosis & Prevention
8:05AM - 9:25AM
Chul Kim, MD, MPH (Moderator)
The Art of Oncology: Learning from Patients' Lived Experiences
8:06AM - 8:15AM
Jill Feldman, MA
Lung Cancer Screening in the Smoking and Non-Smoking Population
8:15AM - 8:25AM
Elaine Shum, MD
Integrating Smoking Cessation in the Lung Cancer Control Setting
8:25AM - 8:35AM
Randi M. Williams, PhD, MPH
State of the Art Bronchoscopic Techniques
8:35AM - 8:45AM
Eric D. Anderson, MD
Best Practice: Biomarker Testing in NSCLC
8:45AM - 8:55AM
Ryan D. Gentzler, MD
The Current Utility of Liquid Biopsy
8:55AM - 9:05AM
Natasha B. Leighl, MD, MMSc
DOTATATE: Diagnosis and Treatment
9:05AM - 9:15AM
Giuseppe Esposito, MD
Session I Panel Discussion
9:15AM - 9:25AM
Eric D. Anderson, MD (Panelist)
Giuseppe Esposito, MD (Panelist)
Jill Feldman, MA (Panelist)
Chul Kim, MD, MPH (Moderator)
Natasha B. Leighl, MD, MMSc (Panelist)
Randi M. Williams, PhD, MPH (Panelist)
Elaine Shum, MD (Panelist)
Coffee Break and Visit the Exhibits
9:25AM - 9:40AM
Session II: Early Stage NSCLC
9:40AM - 11:25AM
Ann E. Hwalek, MD (Moderator)
Treatment of Unresectable Stage III NSCLC
9:40AM - 9:50AM
Michael E. Menefee, MD
When is Proton Radiation Appropriate?
9:50AM - 10:00AM
Nitika Paudel, MD, PhD
Can We Convert Unresectable to Resectable?
10:00AM - 10:10AM
Jonathan Spicer, MD
CheckMate 816: A History
10:10AM - 10:20AM
Patrick Forde, NA
Adjuvant Versus Neoadjuvant Immunotherapy for NSCLC
10:20AM - 10:30AM
Marina Chiara Garassino, MBBS
Targeted Therapy in Early Stage NSCLC
10:30AM - 10:40AM
Narjust Florez, MD
Sub-Lobar Resection for NSCLC
10:40AM - 10:50AM
Ann E. Hwalek, MD
Session II Panel Discussion
10:50AM - 11:00AM
Narjust Florez, MD (Panelist)
Patrick Forde, NA (Panelist)
Marina Chiara Garassino, MBBS (Panelist)
Nitika Paudel, MD, PhD (Panelist)
Brendon M. Stiles, MD (Panelist)
Drew Moghanaki, MD, MPH (Panelist)
Ann E. Hwalek, MD (Moderator)
Debate Introduction
11:00AM - 11:05AM
Joshua E. Reuss, MD
Debate: SBRT for Stage I NSCLC Not Eligible for Lobectomy
11:05AM - 11:15AM
Drew Moghanaki, MD, MPH
Debate: Sub-Lobar Resection for Stage I
11:15AM - 11:25AM
Brendon M. Stiles, MD
Lunch and Visit the Exhibits
11:25AM - 11:55AM
Lunch Symposium: Personalizing Treatment for Adult Patients with Advanced NSCLC
11:55AM - 12:40PM

Sponsored by Regeneron

This symposium is not certified for continuing education credit.


Dessert and Visit the Exhibits
12:40PM - 1:10PM
Session III: Targeted Therapy for Advanced NSCLC #1
1:10PM - 2:20PM
Joshua E. Reuss, MD (Moderator)
Management of Sensitizing EGFR Mutant NSCLC
1:11PM - 1:20PM
Zofia Piotrowska, MD, MHS
Progress for EGFR Exon 20 Insertion NSCLC
1:20PM - 1:30PM
Chul Kim, MD, MPH
Best Practice for ALK + NSCLC
1:30PM - 1:40PM
Jessica J. Lin, MD
Targeting ROS1, NTRK, and NRG1 Fusions in NSCLC
1:40PM - 1:50PM
Faysal Haroun, MD
BRAF: V600E and Beyond
1:50PM - 2:00PM
Ibiayi Dagogo-Jack, MD
Updates on HER2 and RET in NSCLC
2:00PM - 2:10PM
Amin Benyounes, MD
Session III Panel Discussion
2:10PM - 2:20PM
Ibiayi Dagogo-Jack, MD (Panelist)
Amin Benyounes, MD (Panelist)
Faysal Haroun, MD (Panelist)
Chul Kim, MD, MPH (Panelist)
Jessica J. Lin, MD (Panelist)
Zofia Piotrowska, MD, MHS (Panelist)
Joshua E. Reuss, MD (Moderator)
Afternoon Break and Visit the Exhibits
2:20PM - 2:30PM
Session IV: Immunotherapy for Advanced Lung Cancer
2:30PM - 3:55PM
Chul Kim, MD, MPH
Updates in SCLC: Is a Personalized Approach Possible?
2:30PM - 2:40PM
Nagla F. Abdel Karim, MD
Mesothelioma: State of the Art
2:40PM - 2:50PM
Raffit Hassan, MD
Competing Strategies for NSCLS PD-L1 = 50%: Which One Should We Pick?
2:50PM - 3:00PM
Benjamin P. Levy, MD
Immunotherapy Combinations for PD-L1 Low and Negative NSCLC
3:00PM - 3:10PM
Hossein Borghaei, DO, MS
Immunotherapy Toxicity
3:10PM - 3:20PM
Laura Macke, MS, FNP-C, AOCNP
Session IV Panel Discussion
3:20PM - 3:30PM
Hossein Borghaei, DO, MS (Panelist)
Susan C. Scott, MD, MA (Panelist)
Raffit Hassan, MD (Panelist)
Chul Kim, MD, MPH (Moderator)
Benjamin P. Levy, MD (Panelist)
Joshua E. Reuss, MD (Panelist)
Laura Macke, MS, FNP-C, AOCNP (Panelist)
Debate Introduction
3:30PM - 3:35PM
Chul Kim, MD, MPH
Debate: STK11 / KEAP1 Influence Use of IO
3:35PM - 3:45PM
Susan C. Scott, MD, MA
Debate: STK11 / KEAP1 Do Not Influence Use of IO
3:45PM - 3:55PM
Joshua E. Reuss, MD
Afternoon Break & Visit the Exhibits
3:55PM - 4:05PM
Session V: Targeted Therapy for Advanced NSCLC #2
4:05PM - 5:00PM
Jennifer A. Marks, MD
Don't Skip MET!
4:06PM - 4:15PM
Balazs Halmos, MD
Antibody Drug Conjugates for Lung Cancer
4:15PM - 4:25PM
Katherine A. Scilla, MD, FACP
KRAS G12C in NSCLC
4:25PM - 4:35PM
Irina G. Veytsman, MD
KRAS: Beyond G12C
4:35PM - 4:45PM
Alexander I. Spira, MD
Tumor Treating Fields and Thoracic Tumors
4:45PM - 4:55PM
Ticiana Leal, MD
Session V Panel Discussion
4:55PM - 5:00PM
Balazs Halmos, MD
Irina G. Veytsman, MD
Katherine A. Scilla, MD, FACP
Alexander I. Spira, MD
Ticiana Leal, MD
Jennifer A. Marks, MD (Moderator)
Closing Remarks and Conference Adjourn
5:00PM - 5:01PM

If you are interested in supporting the program, please contact Elizabeth Romano at [email protected]


Contact Us

MedStar Health, Department of Continuing Professional Education
[email protected]
CE.MedStarHealth.org